飞秒激光辅助白内障手术对糖尿病患者角膜影响的回顾性研究
该回顾性病例对照研究纳入107例糖尿病患者,比较飞秒激光辅助白内障手术(FLACS)与传统超声乳化白内障吸除术(CPCS)的临床结局。结果显示FLACS组术后早期视力恢复更快,角膜内皮细胞丢失更少,早期角膜水肿更轻,黄斑水肿发生率更低。
要点
- 糖尿病患者FLACS术后1天和1周最佳矫正视力优于传统超声乳化组。
- FLACS组术后3个月角膜内皮细胞丢失中位数205个/mm²,低于对照组的434个/mm²。
- FLACS组术后早期角膜水肿发生率19.2%,低于对照组的38.2%。
核心结论
- 对糖尿病患者,FLACS较传统超声乳化白内障吸除术能加速术后早期视力恢复并提供更好的角膜保护。
研究设计与样本
- 回顾性病例对照研究,纳入2024年5月至2025年4月成都爱迪眼科医院107例(107眼)糖尿病患者,FLACS组52眼,CPCS对照组55眼。
主要发现
- 术后1天最佳矫正视力中位数FLACS组0.2(0.1,0.4),对照组0.3(0.2,0.6),术后1周分别为0.1(0.0,0.2)和0.1(0.1,0.3),差异均有统计学意义(均P<0.05)。
- 术后3个月角膜内皮细胞丢失中位数FLACS组205(74,423)个/mm²,对照组434(268,616)个/mm²,差异有统计学意义(P<0.05)。
- 术后1天中央角膜厚度FLACS组(573.71±52.24)μm,对照组(592.29±41.79)μm,对照组增厚更明显(P<0.05)。
- 术后早期角膜水肿发生率FLACS组19.2%(10/52),对照组38.2%(21/55);对照组术后3个月发生2例黄斑水肿,FLACS组无黄斑水肿(P<0.05)。
临床怎么用
- 糖尿病患者行白内障手术时可优先考虑FLACS,以加速早期视力恢复并减少角膜内皮损伤和早期角膜水肿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: This study aimed to compare the clinical outcomes of femtosecond laser-assisted cataract surgery (FLACS) and conventional phacoemulsification cataract surgery (CPCS) in diabetic patients, and to investigate whether FLACS provides superior early postoperative visual quality recovery. Methods: A retrospective case-control study was performed. A total of 107 diabetic patients (107 eyes) who underwent cataract surgery at Chengdu Aidi Eye Hospital between May 2024 and April 2025 were enrolled. Patients were divided into the FLACS group (52 patients, 52 eyes) and the CPCS control group (55 patients, 55 eyes) according to the surgical technique. Preoperative and postoperative follow-up data within 3 months were collected. Clinical outcomes including best-corrected visual acuity (BCVA), intraocular pressure (IOP), corneal endothelial cell count, central corneal thickness (CCT), and intraoperative and postoperative complications were analyzed and compared between groups. Results: In the control group, the mean age was (70.82±8.41) years, including 25 males and 30 females. In the FLACS group, the mean age was (67.17±9.49) years, including 30 males and 22 females. No significant differences were observed in baseline characteristics such as gender, age, or lens nuclear hardness between the two groups (P>0.05). Preoperative BCVA, IOP, CCT, and corneal endothelial cell count were comparable between groups (P>0.05). At early postoperative time points (1 day and 1 week), BCVA in the FLACS group was significantly better than that in the control group: at 1 day postoperatively, the median BCVA (interquartile range) was 0.3 (0.2, 0.6) in the control group and 0.2 (0.1, 0.4) in the FLACS group; at 1 week postoperatively, it was 0.1 (0.1, 0.3) in the control group and 0.1 (0.0, 0.2) in the FLACS group (all P<0.05). At 1 month and 3 months postoperatively, no significant difference in visual acuity was detected between groups (P>0.05). Corneal endothelial cell loss was significantly lower in the FLACS group than in the control group at all postoperative follow-up time points. At 3 months, median endothelial cell loss was 434 (268, 616) cells/mm2 in the control group and 205 (74, 423) cells/mm2 in the FLACS group (P<0.05). On postoperative day 1, CCT increased to (592.29±41.79) μm in the control group and (573.71±52.24) μm in the FLACS group; the degree of corneal thickening was significantly greater in the control group (P<0.05), indicating more severe corneal edema. This difference was no longer significant from postoperative week 1 onward (P>0.05). IOP was similar between the two groups at all postoperative time points (P>0.05). The incidence of early postoperative corneal edema was significantly higher in the control group (38.2%, 21/55) than in the FLACS group (19.2%, 10/52). During the 3-month follow-up period, macular edema occurred in 2 cases in the control group, while no cases were observed in the FLACS group (P<0.05). Conclusions: For diabetic patients, FLACS significantly accelerates early postoperative visual rehabilitation and provides superior corneal protection, with less corneal endothelial cell loss and milder early postoperative corneal edema. FLACS thus demonstrates higher safety and faster recovery, and may be considered a preferred surgical option for cataract surgery in diabetic patients. 目的: 探讨飞秒激光辅助白内障摘除手术(FLACS)相较于传统超声乳化白内障吸除术对于糖尿病患者在术后早期是否具有更优的视觉恢复效果。 方法: 回顾性队列研究。纳入自2024年5月至2025年4月期间在成都爱迪眼科医院行白内障摘除手术的糖尿病患者107例(107只眼),根据手术方式分为FLACS组52例(52只眼)和传统超声乳化白内障吸除术组(对照组)55例(55只眼)。收集患者术前及术后3个月内的随访数据,分析两组术后1 d、1周、1个月、3个月的最佳矫正视力(BCVA)、眼压、中央角膜厚度、中央角膜内皮细胞计数及术中、术后并发症。 结果: 纳入的对照组55例患者年龄为(70.82±8.41)岁,其中男性25例,女性30例;FLACS组52例患者年龄为(67.17±9.49)岁,其中男性30例,女性22例。两组性别、年龄及术前晶状体核硬度、BCVA、眼压、中央角膜厚度、中央角膜内皮细胞计数等基线指标差异均无统计学意义(均P>0.05)。术后早期(1 d、1周)FLACS组BCVA优于对照组[术后1 d:对照组0.3(0.2,0.6)、FLACS组0.2(0.1,0.4);术后1周:对照组0.1(0.1,0.3)、FLACS组0.1(0.0,0.2)],差异有统计学意义(均P<0.05),术后1和3个月两组视力相当(均P>0.05)。FLACS组术后各时间点角膜内皮细胞丢失均少于对照组[术后3个月对照组和FLACS组分别为434(268,616)、205(74,423)个/mm2],差异均有统计学意义(均P<0.05);术后1 d对照组中央角膜厚度增厚更明显[对照组和FLACS组分别为(592.29±41.79)、(573.71±52.24)μm],差异有统计学意义(P<0.05),术后1周及以后该差异消失(均P>0.05)。两组术后各时间点眼压差异均无统计学意义(均P>0.05);术后早期角膜水肿发生率对照组(38.2%,21只眼)高于FLACS组(19.2%,10只眼),且对照组术后3个月出现2例黄斑水肿,FLACS组无黄斑水肿发生,差异有统计学意义(均P<0.05)。 结论: 对于糖尿病患者,FLACS相较于传统超声乳化白内障吸除术能显著提升术后早期视力恢复速度,且对角膜的保护作用更好。.
引用
- Xiong F, Huang SL, Huang Q, et al. [Retrospective study on the effects of femtosecond laser-assisted cataract surgery on the cornea in diabetic patients]. Zhonghua Yan Ke Za Zhi. 2026. PMID: 41946593. doi:10.3760/cma.j.cn112142-20250805-00331
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。